Mateon Therapeutics Competitors and Similar CompaniesClear all

Mateon Therapeutics's competitors and similar companies include CytomX Therapeutics, Xcovery, Cytodyn and Eleison Pharmaceuticals.

	Mateon Therapeutics Mateon Therapeutics is a biopharmaceutical company seeking to significantly improve cancer treatment with vascular targeted therapy.	CytomX Therapeutics CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.	Xcovery Xcovery a biopharmaceutical company discovering and developing medicines to fight advanced tumors.	Cytodyn CytoDyn is a biotechnology company developing therapies to address cancer, HIV, and other autoimmune diseases.	Eleison Pharmaceuticals Eleison Pharmaceuticals is a company engaged in the discovery and commercialization of drug candidates for cancers.
Founding Date	Founding Date 1996	Founding Date 2008	Founding Date 2006	Founding Date 2002	Founding Date 2008
Type	Type Public	Type Public	Type Private	Type Public	Type Private
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations South San Francisco, US HQ	Locations South San Francisco, US HQ	Locations HQ	Locations Vancouver, US HQ	Locations Princeton, US HQ
Employees	Employees 2	Employees 15815% increase	Employees 176% increase	Employees 10	Employees 12
Valuation ($)	Valuation ($) 6.9 m	Valuation ($) 78 m	Valuation ($) N/A	Valuation ($) 164.2 m	Valuation ($) N/A
Financial
Net income	Net income $249m (FY, 2025)	Net income ($17.4m) (FY, 2025)	Net income N/A	Net income $3.7m (FY, 2025)	Net income N/A